These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14457644)

  • 1. [The treatment of arterial hypertension with an adrenergic-blocking agent].
    KODOUNES A; SPANOLIOS G
    Hell Iatr; 1961 Jun; 30():684-8. PubMed ID: 14457644
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic blocking agents in the treatment of hypertension.
    WOLFF FW
    J Chronic Dis; 1961 Feb; 13():133-47. PubMed ID: 13786332
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of arterial hypertension with sympathetic blocking agents.
    O'BRIEN KP; TAYLOR VJ; IBBERTSON HK
    N Z Med J; 1961 Nov; 60():512-8. PubMed ID: 14480821
    [No Abstract]   [Full Text] [Related]  

  • 4. A sympathetic blocking agent, bretylium tosylate (Darenthin), in the treatment of hypertension.
    CONWAY J; LAUWERS P; HOOBLER SW
    J Lab Clin Med; 1961 Feb; 57():199-205. PubMed ID: 13695220
    [No Abstract]   [Full Text] [Related]  

  • 5. Sympathetic-blocking drugs in the management of hypertension.
    LEISHMAN AW
    Practitioner; 1961 Jan; 186():72-80. PubMed ID: 13760586
    [No Abstract]   [Full Text] [Related]  

  • 6. A new sympatholytic and adrenolytic drug; clinical studies on essential hypertension.
    BANNON WG
    Proc Staff Meet Mayo Clin; 1952 Nov; 27(24):475-81. PubMed ID: 13004019
    [No Abstract]   [Full Text] [Related]  

  • 7. A new sympatholytic and adrenolytic drug; clinical studies on pheochromocytoma and essential hypertension.
    ALLEN EV; BANNON WG; UPSON M; HUIZENGA KA; BASTRON JA; WAUGH JM
    Trans Assoc Am Physicians; 1951; 64():109-21. PubMed ID: 14884241
    [No Abstract]   [Full Text] [Related]  

  • 8. Potent hypotensive drugs: comparative analysis of a ganglionic blocking agent and two new sympathetic inhibitors in severe hypertension.
    CALDWELL JR; LAUBINGER G; SCHMIDT KP
    J Mich State Med Soc; 1961 Mar; 60():352-6. PubMed ID: 13689931
    [No Abstract]   [Full Text] [Related]  

  • 9. Pheochromocytoma in children: case report and discussion of the use of adrenolytic agents in conjunction with operation.
    ZINTEL HA; EAGLE JF; SKOK P; ARNAUD S
    Surgery; 1960 Feb; 47():328-39. PubMed ID: 13847601
    [No Abstract]   [Full Text] [Related]  

  • 10. First experiences with a new anti-hypertensive agent 'darenthin'.
    MORRIS R
    S Afr Med J; 1960 Jan; 34():23-4. PubMed ID: 14424345
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypertension with darenthin].
    MENCZEL J; BEN-ISHAI D; LAVIE N; DAVIS E
    Harefuah; 1961 Sep; 61():161-4. PubMed ID: 14472519
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of intravenous infusions of the optical isomers of dibozane (McN-181;1,4-bis[1,4-benzodioxan-2-ylmethyl] piperazine), an adrenergic blocking agent, upon hypertensive subjects.
    KRAMER LB; VAN HORNE R; BELLET S; KOELLE GB
    Am J Med Sci; 1954 Dec; 228(6):614-21. PubMed ID: 13207122
    [No Abstract]   [Full Text] [Related]  

  • 13. Bretylium tosylate: long-term clinical trial of new hypotensive agent.
    STUCKEY D
    Med J Aust; 1960 Jul; 47(2)():166-8. PubMed ID: 13835383
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of essential hypertension with bretylium tosylate].
    ENDERLE J
    Brux Med; 1961 Jan; 41():13-20. PubMed ID: 13696746
    [No Abstract]   [Full Text] [Related]  

  • 15. Bretylium tosylate in treatment of severe hypertension.
    SOMERS K
    Br Med J; 1962 Mar; 1(5282):911-3. PubMed ID: 13915098
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of severe hypertension with bretylium tosylate.
    MONTUSCHI EF; PEARSON HE; WILSON LL
    Br Med J; 1960 Oct; 2(5207):1199-203. PubMed ID: 13772247
    [No Abstract]   [Full Text] [Related]  

  • 17. Bretylium tosylate in the treatment of hypertension.
    DOLLERY CT; EMSLIE-SMITH D; McMICHAEL J
    Lancet; 1960 Feb; 1(7119):296-9. PubMed ID: 13817333
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial of bretylium tosylate (darenthin) in hypertension.
    SHEE JC; THOMAS JE
    Cent Afr J Med; 1960 May; 6():197-8. PubMed ID: 14445704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bretylium tosylate (Darenthin). Report of an experiment on the clinical significance of bretylium tosylate in the treatment of hypertension].
    ZELVELDER WG
    Ned Tijdschr Geneeskd; 1961 Jun; 105():1260-6. PubMed ID: 13788182
    [No Abstract]   [Full Text] [Related]  

  • 20. Sympathetic blockade in treatment of hypertension. Clinical trial of bretylium tosylate.
    LOWTHER CP; TURNER RW
    Br Med J; 1960 Oct; 2(5205):1049-53. PubMed ID: 13763868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.